RE:RE:RE:Excellent visit with OCO todayOne thing to remember is the share price of Oroco is miles ahead of where it was for other companies in the space. It touched a $600m market cap with NO DRILLING. Filo didn't do that. Solaris didn't do that. Yes, I know there is historical drilling which derisks the project, but major institutions are likely waiting for 43-101 complaint assays before putting in big money.
My point is that I don't think management should be particularly concerned about the share price, volume, or company valuation at this point (and I don't think they are). The focus right now is drilling and with good assays will come volume and share price appreciation. Typically in this space companies stay penny stocks until assays; Oroco is an exception due to historical data and awareness from retail investors such as Mariusz.
Once assay results start getting released the company will likely look to do another raise to fund an expansion of the drilling program and get 6+ rigs going and see some scale economies form in the drilling process. It is at that point that I think a wider range of investors will start to take interest in the company (assuming assays are positive, but Adam all but hinted that they were seeing what they wanted to) and the company will begin to more aggresively market the ticker to see an increase in share price and increase the raise value of a ~10m share private placement.
My advice is sit back and ignore the share price until assays come out. If we're lucky we may start to see a "buy the rumour" trend in October from people trying to front run the release.
Cheers, CU later :)